BOSTON, MA--(Marketwire - December 17, 2009) - KIKA Clinical Solutions
announced that global radiosurgery leader Accuray Incorporated (NASDAQ: ARAY) has chosen KIKA's Veracity™ Web-based EDC system to improve data quality
and decision making on clinical studies that use Accuray's CyberKnife®
Robotic Radiosurgery System. KIKA is the leading provider of advanced EDC
solutions for clinical trials.
Accuray, based in Sunnyvale, Calif., developed and markets the CyberKnife
System to extend the benefits of radiosurgery to include extracranial
tumors. The CyberKnife System has been used to treat more than 70,000
patients in hospitals in the Americas, Europe and Asia. Accuray migrated to
the Veracity™ EDC system based on its successful application of KIKA's
prior clinical trial management product called Eventa™.
In participating CyberKnife System clinical studies, Veracity™'s
database will complete the central imaging review and completely manage the
Imaging plays a vital role in CyberKnife System clinical studies.
Diagnostic images identify the target and help determine patient
eligibility criteria. Treatment images aid in the development and delivery
of a treatment plan. Follow-up images help to assess treatment response.
Imaging also is vital in physics credentialing and quality assurance.
Joanne Davis, Ph.D., Director of Clinical Programs at Accuray, explained
Veracity's benefits: "Imaging review for multicenter clinical studies
creates a variation in image interpretation and analysis. Central review
and database management provides a streamlined process for credentialing
and quality assurance. Participants are guided through the system to ensure
there are no missing data. It decreases the time required to submit and
review plans, and ensures that participants are properly trained and able
to design quality patient treatment plans that adhere to protocol
KIKA's Veracity™ is a highly configurable, collaborative platform. It
enables all clinical trial stakeholders to collect, monitor, adjudicate,
analyze and manage clinical study data in real time and store them into a
CDISC-ready database. Veracity™'s imaging capabilities replace outmoded,
inaccurate and slow methods such as courier services or FTP sites.
Additionally, Veracity™ is supported by an ISO-certified quality
environment. It enables regulatory compliance including 21 CFR Part 11.
KIKA CEO Linda Beneze said, "We're pleased that Veracity will be part of
Accuray's groundbreaking radiosurgery success. Only Veracity can guarantee
the most accurate, timely and detailed clinical trial data."
About KIKA Clinical Solutions
KIKA helps the world's most innovative biopharmaceutical and medical device
organizations use advanced EDC solutions to bring much-needed medical
solutions to market faster. KIKA's Veracity™ is the
leading-edge Web-based clinical trial software platform that delivers
Clinical Asset Management™ for any size clinical trial. Veracity is
customized to meet study needs precisely. It provides unmatched flexibility
and customization with advanced EDC including images and online
adjudication. Veracity is backed by the industry's most reliable IT
infrastructure and a world class Professional Services organization. For
more information, visit www.kikaclinicalsolutions.com.
KIKA, Veracity and Clinical Asset Management are trademarks of the KIKA
group of companies.